NCX-470

NCX-470 · Nicox Ophthalmics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NCX-470, covering 2022-12-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]